Tag: overall survival

Phase 3 EMBARK Study Confirms XTANDI Plus Leuprolide Improves Overall Survival in Non-Metastatic Prostate Cancer

Pfizer Inc. and Astellas Pharma Inc. announced positive topline results from the…

ME Desk

Amgen’s Cancer Therapy Meets Key Goal in Phase 3 Gastric Cancer Study

Amgen announced the Phase 3 FORTITUDE-101 clinical trial evaluating first-line bemarituzumab plus chemotherapy (mFOLFOX6)…

ME Desk